k141_758748_14	SARG|gb|AAC75314.1|ARO:3003578|pmrF	32.2	311	319	322	2.47e-43	150
k141_758748_18	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	39.7	229	232	231	5.00e-45	149
k141_758748_18	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	37.0	227	232	232	1.01e-41	140
k141_758748_18	CARD|gb|ATC67679.1|ARO:3000838|arlR	35.9	220	232	219	4.93e-39	133
k141_758748_18	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	30.6	232	232	232	7.29e-35	123
k141_758748_18	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	30.2	232	232	232	1.44e-34	122
k141_758748_18	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	34.9	232	232	231	7.78e-34	120
k141_758748_18	NCBI|WP_001280781.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	34.1	232	232	231	1.54e-33	119
k141_758748_18	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	34.3	233	232	231	2.17e-33	119
k141_758748_18	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	34.3	230	232	231	4.29e-33	118
k141_758748_18	NCBI|WP_063856720.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	34.5	232	232	231	8.48e-33	117
k141_140668_32	megares|MEG_5400|Drugs|beta-lactam|Penicillin_binding_protein|PBP2_1	30.9	592	617	633	1.33e-64	223
k141_140668_32	ResF|penA_1_AF515059_1	22.0	586	617	581	3.48e-16	80.9
k141_1379563_1	NCBI|ACO06752.1|1|1|emhB|emhB|efflux|1|EFFLUX|EFFLUX|efflux_RND_transporter_permease_subunit_EmhB|AMR|efflux	27.8	295	289	1054	1.35e-27	111
k141_1379563_1	SARG|gi|921173670|ref|WP_053119224.1|	27.8	295	289	1054	1.35e-27	111
k141_1379563_1	CARD|gb|AAG07594.1|ARO:3000808|MexI	25.5	255	289	1029	3.29e-19	86.7
k141_1379563_2	SARG|gi|959841567|ref|WP_058129433.1|	26.8	299	345	370	1.15e-21	93.6
k141_1379563_2	SARG|gi|489243583|ref|WP_003151780.1|	26.8	299	345	370	1.15e-21	93.6
k141_1379563_2	SARG|gi|759372331|ref|WP_043100492.1|	26.8	299	345	370	1.57e-21	93.2
k141_1379563_2	SARG|gi|959851615|ref|WP_058135529.1|	26.8	299	345	370	1.57e-21	93.2
k141_1379563_2	SARG|YP_001346278	26.8	299	345	370	1.57e-21	93.2
k141_1379563_2	SARG|gi|730722324|ref|WP_034081431.1|	26.4	299	345	370	2.14e-21	92.8
k141_1379563_9	CARD|gb|AAK37618.1|ARO:3005008|TxR	41.5	241	422	318	2.40e-56	187
k141_831318_4	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	38.7	333	304	703	2.79e-63	211
k141_1449774_5	NCBI|WP_005812825.1|1|1|nimJ|nimJ|nitroimidazole_reductase|2|NITROIMIDAZOLE|NITROIMIDAZOLE|5-nitroimidazole_reductase_NimJ|AMR|nitroimidazole	80.4	158	166	165	1.01e-89	258
k141_1449774_5	NCBI|WP_021588763.1|1|1|nimI|nimI|nitroimidazole_reductase|2|NITROIMIDAZOLE|NITROIMIDAZOLE|5-nitroimidazole_reductase_NimI|AMR|nitroimidazole	74.8	159	166	172	2.14e-81	237
k141_1449774_5	ResF|nimI_1_FJ940883_1	75.2	157	166	165	3.41e-81	236
k141_1449774_5	ResF|nimI_1_FJ940884_1	75.2	157	166	165	6.87e-81	235
k141_1449774_5	ResF|nimI_1_FJ940887_1	74.5	157	166	165	6.87e-81	235
k141_1449774_5	ResF|nimI_1_FJ940889_1	73.9	157	166	165	3.97e-80	233
k141_1449774_5	ResF|nimI_1_FJ940886_1	73.9	157	166	165	5.63e-80	233
k141_1449774_5	megares|MEG_4192|Drugs|Metronidazole|nim_nitroimidazole_reductase|NIMI_1	73.9	153	166	154	5.29e-78	228
k141_1449774_5	megares|MEG_4189|Drugs|Metronidazole|nim_nitroimidazole_reductase|NIMI_1	74.8	151	166	152	7.03e-78	227
k141_1449774_5	megares|MEG_4190|Drugs|Metronidazole|nim_nitroimidazole_reductase|NIMI_1	74.8	151	166	152	1.42e-77	226
k141_764549_28	megares|MEG_5148|Drugs|beta-lactam|Class_D_betalactamases|OXA_1	26.6	256	331	346	6.45e-15	73.6
k141_146856_1	SARG|gi|1035706844|ref|WP_064548272.1|	32.1	81	780	648	2.97e-06	49.7
k141_1249388_7	SARG|gi|696368937|ref|WP_032943949.1|	42.9	219	223	648	6.91e-55	184
k141_1249388_7	SARG|gi|851913025|ref|WP_048215946.1|	42.9	219	223	648	6.91e-55	184
k141_1249388_7	SARG|YP_002850060	42.9	219	223	648	6.91e-55	184
k141_1249388_7	SARG|gi|489930965|ref|WP_003834285.1|	42.9	219	223	648	6.91e-55	184
k141_1249388_7	SARG|gi|851922185|ref|WP_048218206.1|	42.9	219	223	648	1.34e-54	183
k141_1249388_7	SARG|gi|949718947|ref|WP_057063453.1|	42.9	219	223	648	1.34e-54	183
k141_1249388_7	SARG|gi|696375069|ref|WP_032949617.1|	42.9	219	223	648	1.34e-54	183
k141_1249388_7	SARG|gi|696361545|ref|WP_032936694.1|	42.9	219	223	648	1.34e-54	183
k141_1249388_7	SARG|gi|489936909|ref|WP_003840216.1|	42.9	219	223	648	1.34e-54	183
k141_1249388_7	SARG|gi|489127020|ref|WP_003036815.1|	42.9	219	223	648	1.34e-54	183
k141_1249388_14	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	36.4	599	645	655	4.14e-112	350
k141_1249388_14	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	36.2	599	645	655	1.62e-111	348
k141_1249388_14	SARG|gb|AKA86814|ARO:3003746|optrA	36.2	599	645	655	1.62e-111	348
k141_1249388_14	megares|MEG_4309|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	36.2	599	645	655	6.31e-111	347
k141_1249388_14	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	36.2	599	645	655	1.25e-110	346
k141_1249388_14	megares|MEG_4312|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	36.2	599	645	655	1.25e-110	346
k141_1249388_14	megares|MEG_4315|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	36.2	599	645	655	1.25e-110	346
k141_1249388_14	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	36.2	599	645	655	2.46e-110	345
k141_1249388_14	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	36.1	599	645	655	2.46e-110	345
k141_1249388_14	megares|MEG_4323|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	36.1	599	645	655	6.84e-110	344
k141_838789_3	SARG|HE999704.1.gene3064.p01	29.8	235	477	241	1.20e-28	112
k141_839109_2	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	37.6	205	259	307	1.45e-36	130
k141_839109_2	SARG|gi|542061059|gb|ERI11611.1|	37.5	232	259	316	1.01e-34	125
k141_839109_2	SARG|gi|507050365|ref|WP_016121371.1|	38.3	222	259	309	1.22e-34	125
k141_839109_2	SARG|gi|447195836|ref|WP_001273092.1|	34.9	229	259	306	1.60e-34	125
k141_839109_2	SARG|gi|488120365|ref|WP_002191762.1|	37.9	211	259	309	2.39e-34	124
k141_839109_2	SARG|gi|507055561|ref|WP_016126482.1|	38.3	206	259	309	2.39e-34	124
k141_839109_2	SARG|gi|488053456|ref|WP_002124853.1|	39.4	208	259	309	3.35e-34	124
k141_839109_2	SARG|gi|488130770|ref|WP_002201978.1|	39.4	208	259	309	3.35e-34	124
k141_839109_2	SARG|gi|447195835|ref|WP_001273091.1|	34.5	229	259	306	4.40e-34	124
k141_839109_2	SARG|gi|488067981|ref|WP_002139378.1|	38.9	208	259	309	9.18e-34	123
k141_839109_18	SARG|ABN79417	25.5	443	611	639	6.09e-26	111
k141_839109_18	SARG|AAO42740	25.3	443	611	639	1.08e-25	110
k141_839109_18	SARG|AY485126.gene.p01	25.3	443	611	639	1.08e-25	110
k141_839109_18	megares|MEG_7175|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	25.3	443	611	639	1.08e-25	110
k141_839109_18	megares|MEG_7174|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	26.2	443	611	629	2.46e-25	109
k141_839109_18	SARG|ABV82118	23.0	440	611	639	2.54e-25	109
k141_839109_18	SARG|gi|1004359922|gb|AMP42228.1|	25.7	443	611	639	2.54e-25	109
k141_839109_18	ResF|tet(O/W)_2_AM889119_1	26.2	443	611	639	2.54e-25	109
k141_839109_18	SARG|Q08425	24.9	474	611	641	3.39e-25	109
k141_839109_18	megares|MEG_7181|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETQ_1	24.9	474	611	657	3.55e-25	109
k141_839109_20	NCBI|WP_004212918.1|1|1|oqxA11|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA11|AMR|multidrug	24.8	371	346	391	2.99e-18	84.0
k141_839109_20	NCBI|WP_004890321.1|1|1|oqxA3|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA3|AMR|multidrug	24.8	371	346	391	2.99e-18	84.0
k141_839109_20	NCBI|WP_063865368.1|1|1|oqxA4|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA4|AMR|multidrug	24.8	371	346	391	4.05e-18	83.6
k141_839109_20	NCBI|WP_047693838.1|1|1|oqxA6|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA6|AMR|multidrug	24.5	371	346	391	1.00e-17	82.4
k141_839109_20	SARG|gb|AAP43109.1|ARO:3003922|oqxA	24.5	371	346	391	1.35e-17	82.0
k141_839109_20	NCBI|WP_063865358.1|1|1|oqxA2|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA2|AMR|multidrug	24.5	371	346	391	1.35e-17	82.0
k141_839109_20	NCBI|WP_063865373.1|1|1|oqxA5|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA5|AMR|multidrug	24.5	371	346	391	1.35e-17	82.0
k141_839109_20	NCBI|WP_063865399.1|1|1|oqxA9|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA9|AMR|multidrug	24.5	371	346	391	1.35e-17	82.0
k141_839109_20	NCBI|WP_004149398.1|1|1|oqxA10|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA10|AMR|multidrug	24.5	371	346	391	1.83e-17	81.6
k141_839109_20	NCBI|WP_063865390.1|1|1|oqxA8|oqxA|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_periplasmic_adaptor_subunit_OqxA8|AMR|multidrug	24.8	371	346	391	2.47e-17	81.3
k141_839109_21	SARG|gb|AAG07064.1|ARO:3003693|mexK	25.7	1028	1041	1025	4.54e-89	307
k141_839109_21	CARD|gb|AAG03548.1|ARO:3003681|TriC	24.5	1021	1041	1015	1.25e-87	303
k141_839109_21	CARD|gb|AAC75136.1|ARO:3000793|mdtB	25.1	1032	1041	1040	7.26e-66	240
k141_839109_21	NCBI|AAN33534.1|1|1|bepG|bepG|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_permease_subunit_BepG|AMR|efflux	24.8	1017	1041	1074	5.61e-64	234
k141_839109_21	NCBI|WP_063865404.1|1|1|oqxB10|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB10|AMR|multidrug	23.3	1006	1041	1050	1.74e-58	218
k141_839109_21	NCBI|WP_063865519.1|1|1|oqxB28|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB28|AMR|multidrug	23.3	1006	1041	1050	2.33e-58	217
k141_839109_21	NCBI|WP_004899982.1|1|1|oqxB17|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB17|AMR|multidrug	23.2	1006	1041	1050	3.10e-58	217
k141_839109_21	NCBI|WP_021312368.1|1|1|oqxB20|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB20|AMR|multidrug	23.2	1006	1041	1050	4.14e-58	216
k141_839109_21	NCBI|WP_004149399.1|1|1|oqxB19|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB19|AMR|multidrug	23.2	1006	1041	1050	4.14e-58	216
k141_839109_21	NCBI|WP_063865413.1|1|1|oqxB12|oqxB|efflux|2|PHENICOL/quinolone|PHENICOL/quinolone|multidrug_efflux_RND_transporter_permease_subunit_OqxB12|AMR|multidrug	23.2	1006	1041	1050	4.14e-58	216
k141_564625_17	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	26.6	711	642	703	8.56e-48	177
k141_774411_22	SARG|U19459.gene.p01	31.6	95	180	212	9.60e-11	57.4
k141_774411_22	SARG|YP_001779894	34.2	76	180	212	6.11e-09	52.4
k141_774411_22	SARG|YP_002861121	34.2	76	180	212	8.39e-09	52.0
k141_774411_22	SARG|GQ205627.2.gene3.p01	32.6	95	180	216	8.70e-09	52.0
k141_774411_22	SARG|YP_001389621	32.9	76	180	212	1.58e-08	51.2
k141_774411_22	SARG|gb|AAF63432|ARO:3003744|vatF	46.0	50	180	221	1.70e-08	51.2
k141_774411_22	SARG|YP_001785579	32.9	76	180	212	2.97e-08	50.4
k141_774411_22	SARG|AF015628.1.gene2.p01	48.0	50	180	212	4.07e-08	50.1
k141_1531479_17	megares|MEG_5148|Drugs|beta-lactam|Class_D_betalactamases|OXA_1	31.6	215	301	346	2.85e-21	91.3
k141_1325967_1	SARG|gi|498515089|ref|WP_010815296.1|	35.5	242	269	323	1.72e-38	136
k141_1325967_1	SARG|gi|985522333|ref|WP_060811962.1|	35.1	242	269	323	6.64e-38	134
k141_1325967_1	SARG|NP_878015	31.8	245	269	322	4.92e-37	132
k141_1325967_1	SARG|gi|737310392|ref|WP_035293250.1|	33.9	245	269	323	5.31e-36	129
k141_1325967_1	SARG|gi|738848198|ref|WP_036737307.1|	32.7	245	269	323	1.46e-35	128
k141_1325967_1	SARG|DQ018711.1.gene4.p01	33.9	245	269	322	2.00e-35	128
k141_1325967_1	SARG|KF478993.1.gene2.p01	31.9	254	269	350	9.46e-35	127
k141_1325967_1	SARG|gi|746609237|ref|WP_039635344.1|	32.0	259	269	322	2.09e-34	125
k141_1325967_1	SARG|AF155139.2.gene6.p01	34.3	242	269	322	2.93e-34	125
k141_1325967_1	SARG|AAR37059	32.2	242	269	323	4.18e-34	124
k141_1325967_4	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	36.7	229	233	231	6.46e-43	144
k141_1325967_4	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	37.8	230	233	232	1.05e-41	140
k141_1325967_4	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	37.9	224	233	228	9.12e-39	133
k141_1325967_4	NCBI|WP_002317273.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	32.6	224	233	219	5.39e-35	123
k141_1325967_4	NCBI|WP_063856719.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	32.6	224	233	220	5.53e-35	123
k141_1325967_4	NCBI|WP_032489743.1|1|1|vanR-B|vanR-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-B|AMR|glycopeptide	32.6	224	233	220	7.78e-35	122
k141_1325967_4	NCBI|WP_063856724.1|1|1|vanR-L|vanR-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-L|AMR|glycopeptide	33.0	230	233	231	1.33e-31	114
k141_1325967_4	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	33.5	230	233	231	7.31e-31	112
k141_1325967_4	NCBI|WP_003126775.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	33.5	230	233	231	7.31e-31	112
k141_1325967_4	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	33.5	230	233	231	7.31e-31	112
k141_1325967_5	NCBI|WP_063856732.1|1|1|vanS-G|vanS-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-G|AMR|glycopeptide	28.8	229	285	367	3.96e-31	118
k141_1325967_5	NCBI|WP_021418927.1|1|1|vanS-G|vanS-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-G|AMR|glycopeptide	28.8	229	285	368	4.03e-31	118
k141_1325967_5	megares|MEG_7507|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	29.0	224	285	381	3.52e-30	115
k141_1325967_5	NCBI|WP_063856738.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	29.0	224	285	381	3.52e-30	115
k141_1325967_5	NCBI|WP_063856744.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	30.8	208	285	381	4.87e-30	115
k141_1325967_5	megares|MEG_7504|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	30.8	208	285	381	4.87e-30	115
k141_1325967_5	NCBI|WP_028530133.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	28.6	224	285	381	6.76e-30	115
k141_1325967_5	megares|MEG_7506|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	28.6	224	285	381	6.76e-30	115
k141_1325967_5	megares|MEG_7505|Drugs|Glycopeptide|VanD-type_regulator|VANSD_1	28.6	224	285	381	1.30e-29	114
k141_1325967_5	NCBI|WP_063856730.1|1|1|vanS-D|vanS-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-D|AMR|glycopeptide	28.6	224	285	381	1.30e-29	114
k141_641927_8	SARG|ZP_04635128	32.4	364	750	543	8.57e-40	153
k141_641927_8	SARG|ZP_04612557	33.8	364	750	543	1.16e-39	153
k141_641927_8	SARG|ZP_04631861	32.7	364	750	543	1.57e-39	152
k141_641927_8	SARG|gi|318604694|emb|CBY26192.1|	32.4	364	750	540	2.75e-39	152
k141_641927_8	SARG|YP_001007250	32.4	364	750	563	3.68e-39	152
k141_641927_8	SARG|ZP_04623897	32.4	364	750	543	7.04e-39	150
k141_641927_8	SARG|ZP_04615639	32.8	366	750	543	3.15e-38	149
k141_641927_8	SARG|gi|740410309|ref|WP_038243756.1|	32.8	366	750	563	4.02e-38	149
k141_641927_8	SARG|ZP_04638974	32.7	364	750	563	5.42e-38	148
k141_641927_8	SARG|ZP_04630103	32.4	364	750	543	5.73e-38	148
k141_1397352_13	SARG|gb|ABA71733.1|ARO:3002972|vanTG	35.4	373	833	712	1.87e-57	208
k141_1397352_13	NCBI|CZR78671.1|1|1|vanT-Cd|vanT-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-Cd|AMR|glycopeptide	32.1	399	833	712	1.10e-47	180
k141_1397352_13	NCBI|WP_063856752.1|1|1|vanT-G|vanT-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-G|AMR|glycopeptide	33.0	373	833	711	1.60e-46	176
k141_1397352_13	SARG|gi|498467693|ref|WP_010773049.1|	32.3	390	833	700	6.20e-40	156
k141_1397352_13	SARG|AAY67970	31.6	376	833	698	4.64e-39	154
k141_1397352_13	SARG|FJ872411.1.gene43.p01	30.9	369	833	702	3.61e-37	148
k141_1397352_13	megares|MEG_7571|Drugs|Glycopeptide|VanM-type_resistance_protein|VANXM_2	24.9	478	833	451	2.78e-31	127
k141_1397352_13	megares|MEG_7563|Drugs|Glycopeptide|VanB-type_resistance_protein|VANXB_2	23.1	459	833	451	3.97e-30	123
k141_1397352_13	megares|MEG_7572|Drugs|Glycopeptide|VanM-type_resistance_protein|VANXM_2	23.5	468	833	481	5.80e-30	123
k141_1604811_7	SARG|gb|MBY8651252.1|ARO:3007190|vanX_in_vanP_cl	26.6	192	246	202	1.45e-11	60.8
k141_1537024_36	SARG|Q2NWE3	33.0	267	268	273	3.71e-43	147
k141_1537024_36	SARG|YP_001436495	33.3	264	268	272	5.09e-43	146
k141_1537024_36	SARG|BAH65231	33.2	268	268	273	7.35e-43	146
k141_1537024_36	SARG|YP_002236533	33.5	269	268	273	1.04e-42	145
k141_1537024_36	SARG|B2VGJ3	33.6	268	268	273	1.04e-42	145
k141_1537024_36	SARG|ZP_03041263	32.2	264	268	267	2.47e-42	144
k141_1537024_36	SARG|ZP_04616832	33.7	267	268	274	4.17e-42	144
k141_1537024_36	SARG|YP_001480516	33.7	267	268	274	1.16e-41	143
k141_1537024_36	SARG|YP_002847905	32.6	264	268	272	1.55e-41	142
k141_1537024_36	SARG|Q57JQ4	32.1	268	268	273	1.59e-41	142
k141_1537024_47	SARG|DQ018711.1.gene4.p01	25.3	182	307	322	1.74e-12	65.9
k141_1537024_47	SARG|gi|737310392|ref|WP_035293250.1|	24.7	182	307	323	4.63e-11	61.6
k141_1537024_47	SARG|gi|738848198|ref|WP_036737307.1|	24.7	182	307	323	8.87e-10	57.8
k141_1537024_51	SARG|YP_002333394	43.0	230	311	323	7.38e-44	151
k141_1537024_51	SARG|AF310956.2.gene5.p01	42.6	230	311	323	2.86e-43	150
k141_1537024_51	NCBI|WP_063856701.1|1|1|vanH-B|vanH-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-B|AMR|glycopeptide	42.6	230	311	323	2.86e-43	150
k141_1537024_51	SARG|gi|498515089|ref|WP_010815296.1|	41.7	230	311	323	5.63e-43	149
k141_1537024_51	SARG|gi|985522333|ref|WP_060811962.1|	41.7	230	311	323	5.63e-43	149
k141_1537024_51	SARG|Q47748	41.3	230	311	323	8.42e-42	146
k141_1537024_51	SARG|gb|AAB05626.1|ARO:3002943|vanHB	41.3	230	311	323	1.18e-41	145
k141_1537024_51	NCBI|WP_063856700.1|1|1|vanH-Ao2|vanH-Ao2|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ao2|AMR|glycopeptide	39.1	235	311	343	2.60e-41	145
k141_1537024_51	NCBI|WP_063856699.1|1|1|vanH-Ao1|vanH-Ao1|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ao1|AMR|glycopeptide	39.1	235	311	348	2.89e-41	145
k141_1537024_51	SARG|KF478993.1.gene2.p01	42.9	196	311	350	4.23e-41	145
k141_1537024_57	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	39.9	694	647	703	2.40e-153	458
k141_1537024_63	SARG|gb|APB03219.1|ARO:3003986|TaeA	41.9	528	599	648	8.68e-131	396
k141_1537024_63	NCBI|AJP12342.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	30.4	527	599	550	1.21e-57	201
k141_1537024_63	megares|MEG_4322|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	29.4	537	599	655	2.38e-54	194
k141_1537024_63	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.6	539	599	655	8.52e-54	193
k141_1537024_63	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.6	539	599	655	3.05e-53	191
k141_1537024_63	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.6	539	599	655	3.05e-53	191
k141_1537024_63	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.9	539	599	655	7.91e-53	190
k141_1537024_63	megares|MEG_4321|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.4	539	599	655	1.09e-52	190
k141_1537024_63	megares|MEG_4317|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.4	539	599	655	1.09e-52	190
k141_1537024_63	megares|MEG_4314|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	28.4	539	599	655	1.09e-52	190
k141_715678_12	SARG|gb|MBY8651252.1|ARO:3007190|vanX_in_vanP_cl	39.2	212	253	202	4.57e-53	169
k141_715678_12	SARG|gi|522156438|ref|WP_020667646.1|	40.1	212	253	208	8.77e-52	166
k141_715678_12	SARG|gi|654471747|ref|WP_027941974.1|	40.5	210	253	202	4.14e-51	164
k141_715678_12	SARG|gi|651270389|ref|WP_026403570.1|	40.7	209	253	202	3.31e-50	162
k141_715678_12	NCBI|WP_063856768.1|1|1|vanX-Ac1|vanX-Ac1|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-Ala-D-Ala_dipeptidase_VanX-Ac1|AMR|glycopeptide	41.1	209	253	204	7.03e-50	161
k141_715678_12	NCBI|WP_016331866.1|1|1|vanX-Ao2|vanX-Ao2|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-Ala-D-Ala_dipeptidase_VanX-Ao2|AMR|glycopeptide	40.0	210	253	202	1.32e-49	160
k141_715678_12	SARG|gi|494774722|ref|WP_007510130.1|	39.8	211	253	202	1.32e-49	160
k141_715678_12	SARG|gi|40713145|emb|CAE53345.1|	39.7	209	253	202	5.28e-49	159
k141_715678_12	NCBI|WP_063856769.1|1|1|vanX-Ao1|vanX-Ao1|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-Ala-D-Ala_dipeptidase_VanX-Ao1|AMR|glycopeptide	39.5	210	253	202	1.06e-48	158
k141_715678_12	SARG|gi|651279333|ref|WP_026411319.1|	39.7	209	253	202	4.22e-48	157
k141_649170_13	NCBI|WP_031281281.1|1|1|catB|catB|acetyltransferase|2|CHLORAMPHENICOL|PHENICOL|type_B_phenicol_O-acetyltransferase|AMR|phenicol	35.0	140	216	210	8.16e-19	80.1
k141_649170_13	SARG|U19459.gene.p01	32.0	147	216	212	1.19e-14	68.9
k141_649170_13	SARG|YP_002861121	35.9	131	216	212	2.29e-14	68.2
k141_649170_13	SARG|M58472.1.gene1.p01	31.2	138	216	209	4.19e-14	67.4
k141_649170_13	SARG|AF015628.1.gene2.p01	31.7	123	216	212	1.16e-13	66.2
k141_649170_13	SARG|gi|499386493|ref|WP_011073960.1|	33.6	128	216	210	1.56e-13	65.9
k141_649170_13	SARG|gb|AID93387.1|ARO:3004660|catB11	30.9	152	216	210	2.98e-13	65.1
k141_649170_13	SARG|AJ223604.1.gene5.p01	31.7	126	216	210	4.12e-13	64.7
k141_649170_13	SARG|AF445082.1.gene5.p01	32.3	124	216	210	1.08e-12	63.5
k141_649170_13	SARG|ABF20240	32.3	124	216	210	1.50e-12	63.2
k141_649170_19	SARG|gi|502669352|ref|WP_012905216.1|	34.0	203	225	648	1.51e-26	105
k141_649170_19	SARG|gi|500448961|gb|EOP61695.1|	31.4	220	225	306	2.38e-26	102
k141_649170_19	SARG|gi|447195835|ref|WP_001273091.1|	31.2	218	225	306	3.32e-26	102
k141_649170_19	SARG|gi|500465078|gb|EOP76697.1|	31.4	220	225	306	3.32e-26	102
k141_649170_19	SARG|gi|803568669|ref|WP_046077412.1|	31.4	223	225	648	3.80e-26	104
k141_649170_19	SARG|gi|446110352|ref|WP_000188207.1|	31.4	223	225	648	3.80e-26	104
k141_649170_19	SARG|YP_002382193	31.4	223	225	648	3.80e-26	104
k141_649170_19	SARG|gi|803575554|ref|WP_046081557.1|	31.4	223	225	648	3.80e-26	104
k141_649170_19	SARG|gi|446110351|ref|WP_000188206.1|	31.4	223	225	648	3.80e-26	104
k141_649170_19	SARG|gi|488042066|ref|WP_002113463.1|	30.9	220	225	309	6.78e-26	101
k141_649170_23	megares|MEG_6058|Drugs|MLS|23S_rRNA_methyltransferases|RLMH_1	31.4	159	158	159	1.61e-26	97.1
k141_1404661_9	megares|MEG_5409|Drugs|beta-lactam|Penicillin_binding_protein|PBP4B_1	33.1	359	789	434	8.38e-49	177
k141_1404661_9	SARG|AF180958.1.gene1.p01	26.9	260	789	377	2.80e-14	74.3
k141_1404661_9	ResF|blaACC-3_1_AF180958_1	26.9	260	789	389	3.05e-14	74.3
k141_1404661_9	SARG|gb|WP_007888761.1|ARO:3006869|CSA-1	26.3	358	789	375	2.72e-12	68.2
k141_1404661_9	NCBI|WP_063840466.1|1|1|ampC_Sliq-1|ampC_Sliq-1|hydrolase|2|CEPHALOSPORIN|beta-lactam|cephalosporin-hydrolyzing_class_C_beta-lactamase|AMR|beta-lactam	27.5	182	789	378	6.34e-11	63.9
k141_1404661_9	SARG|gb|WP_004384957.1|ARO:3006870|CSA-2	25.7	358	789	375	1.46e-10	62.8
k141_1404661_9	SARG|gi|764984241|ref|WP_044550790.1|	27.5	182	789	378	1.49e-10	62.8
k141_1404661_9	SARG|gb|WP_105620838.1|ARO:3006923|CMA-2	24.8	363	789	375	4.55e-10	61.2
k141_1404661_9	SARG|gb|WP_063857697.1|ARO:3006229|ACC-1b	23.0	261	789	390	6.44e-10	60.8
k141_1404661_9	SARG|gb|WP_063857698.1|ARO:3006230|ACC-1c	22.1	285	789	390	6.44e-10	60.8
k141_858192_3	SARG|YP_371056	22.7	1059	1044	1066	4.67e-67	244
k141_858192_3	SARG|ZP_02465589	23.3	1044	1044	1061	1.47e-66	242
k141_858192_3	SARG|YP_838977	22.4	1059	1044	1061	2.66e-66	241
k141_858192_3	SARG|gi|590120227|emb|CDN64284.1|	22.5	1044	1044	1048	3.25e-66	241
k141_858192_3	SARG|CP000675.2.gene2298.p01	23.4	1070	1044	1052	3.35e-66	241
k141_858192_3	SARG|ZP_02405550	23.3	1061	1044	1061	3.57e-66	241
k141_858192_3	SARG|CAR56416	22.4	1059	1044	1066	3.70e-66	241
k141_858192_3	SARG|ZP_02904980	22.2	1041	1044	1048	4.37e-66	241
k141_858192_3	SARG|ZP_02357857	23.0	1061	1044	1061	4.79e-66	241
k141_858192_3	SARG|YP_001025938	23.2	1061	1044	1061	6.44e-66	240
k141_858192_17	SARG|gb|AYV52072.1|ARO:3002882|lmrD	35.6	295	600	664	1.84e-58	206
k141_858192_17	SARG|gb|AAK76136.1|ARO:3000025|patB	25.3	594	600	588	4.25e-54	192
k141_858192_17	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	25.9	532	600	579	5.41e-46	170
k141_858192_17	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	24.6	581	600	579	1.02e-45	169
k141_858192_17	SARG|gb|AET10445.1|ARO:3004033|tetB(46)	25.1	509	600	578	5.92e-44	164
k141_858192_17	SARG|gb|CDO61516.1|ARO:3003949|efrB	31.5	257	600	362	9.51e-42	153
k141_858192_17	SARG|gb|AAK76137.1|ARO:3000024|patA	25.6	579	600	564	8.86e-39	149
k141_858192_17	SARG|gb|WP_104671188.1|ARO:3003948|efrA	23.7	515	600	575	2.88e-37	145
k141_858192_17	SARG|gi|445983927|ref|WP_000061782.1|	26.7	217	600	492	9.21e-09	57.0
k141_1062829_8	megares|MEG_7571|Drugs|Glycopeptide|VanM-type_resistance_protein|VANXM_2	30.9	350	433	451	2.75e-46	164
k141_1062829_8	megares|MEG_7572|Drugs|Glycopeptide|VanM-type_resistance_protein|VANXM_2	30.4	349	433	481	2.46e-45	162
k141_1062829_8	megares|MEG_7563|Drugs|Glycopeptide|VanB-type_resistance_protein|VANXB_2	30.1	349	433	451	3.83e-45	161
k141_1475455_13	SARG|AAN28721	46.8	79	404	108	2.44e-17	76.3
k141_517226_7	SARG|gb|AAC74000.1|ARO:3003950|msbA	30.3	376	545	582	2.46e-43	161
k141_517226_7	SARG|gi|748767925|ref|WP_040019608.1|	34.7	262	545	623	3.97e-35	138
k141_517226_7	SARG|gi|926400371|ref|WP_053728483.1|	34.0	265	545	603	4.64e-35	138
k141_517226_7	SARG|gi|655401130|ref|WP_028800283.1|	30.9	327	545	599	6.10e-35	137
k141_517226_7	SARG|gi|663350985|ref|WP_030349761.1|	31.9	326	545	613	2.26e-34	136
k141_517226_7	SARG|gi|860594225|ref|WP_048475168.1|	31.3	326	545	620	2.37e-34	136
k141_517226_7	SARG|gi|664244930|ref|WP_030776974.1|	30.6	327	545	601	1.26e-33	134
k141_517226_7	SARG|gi|1011969930|ref|WP_062776015.1|	30.7	264	545	601	1.26e-33	134
k141_517226_7	SARG|gi|655413091|ref|WP_028811890.1|	31.0	326	545	603	1.28e-33	134
k141_517226_7	SARG|gi|930482089|ref|WP_054228897.1|	31.4	264	545	599	1.68e-33	133
k141_998440_3	CARD|gb|BAB41874.1|ARO:3000815|mgrA	36.9	103	145	147	2.64e-18	75.1
k141_656224_9	SARG|gb|CAE00499.1|ARO:3003835|cdeA	28.7	436	468	441	2.05e-56	192
k141_1207916_2	SARG|gb|AAR96051.1|ARO:3002894|otrC	24.6	207	425	351	1.14e-10	61.6
k141_1207916_2	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	26.4	197	425	655	7.88e-09	56.6
k141_1207916_2	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	26.4	197	425	655	1.04e-08	56.2
k141_1207916_2	megares|MEG_4308|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	26.4	197	425	655	1.04e-08	56.2
k141_1207916_2	NCBI|WP_002294513.1|1|1|lsa(E)|lsa(E)|target_protection|2|LINCOSAMIDE/STREPTOGRAMIN|LINCOSAMIDE/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_Lsa(E)|AMR|multidrug	24.7	243	425	494	1.18e-08	55.8
k141_1207916_2	megares|MEG_4321|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	25.9	197	425	655	7.38e-08	53.5
k141_1207916_2	megares|MEG_4317|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	25.9	197	425	655	7.38e-08	53.5
k141_1207916_2	megares|MEG_4322|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	25.9	197	425	655	7.38e-08	53.5
k141_1207916_2	megares|MEG_4314|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	25.9	197	425	655	7.38e-08	53.5
k141_1207916_2	megares|MEG_4323|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	25.9	197	425	655	7.38e-08	53.5
k141_1207916_20	SARG|CAP74085	42.9	91	170	210	7.96e-14	65.5
k141_1207916_20	SARG|M58472.1.gene1.p01	29.9	157	170	209	2.92e-13	63.9
k141_1207916_20	SARG|AAS89471	40.7	91	170	210	1.10e-12	62.4
k141_1207916_20	NCBI|WP_071593228.1|1|2|catB8|catB8|acetyltransferase|2|aminoglycoside/CHLORAMPHENICOL|aminoglycoside/PHENICOL|bifunctional_type_B-3_phenicol_O-acetyltransferase_CatB8/aminoglycoside_N-acetyltransferase_AAC(6')-Ib|AMR|multidrug	41.8	91	170	419	2.48e-12	62.8
k141_1207916_20	SARG|AY123251.gene2.p01	39.6	91	170	210	4.07e-12	60.8
k141_1207916_20	NCBI|WP_010635894.1|1|1|catB8|catB8|acetyltransferase|2|CHLORAMPHENICOL|PHENICOL|type_B-3_phenicol_O-acetyltransferase_CatB8|AMR|phenicol	39.6	91	170	210	4.07e-12	60.8
k141_1207916_20	NCBI|WP_071766400.1|1|1|catB8|catB8|acetyltransferase|2|CHLORAMPHENICOL|PHENICOL|type_B-3_phenicol_O-acetyltransferase_CatB8|AMR|phenicol	39.6	91	170	210	4.07e-12	60.8
k141_1207916_20	NCBI|WP_021018581.1|1|1|catB8|catB8|acetyltransferase|2|CHLORAMPHENICOL|PHENICOL|type_B-3_phenicol_O-acetyltransferase_CatB8|AMR|phenicol	39.6	91	170	210	5.64e-12	60.5
k141_1207916_20	SARG|FJ460181.2.gene2.p01	39.6	91	170	210	5.64e-12	60.5
k141_1207916_20	SARG|X82455.1.gene1.p01	38.5	91	170	210	7.81e-12	60.1
k141_1207916_28	SARG|gi|507050365|ref|WP_016121371.1|	38.5	218	231	309	2.09e-53	173
k141_1207916_28	SARG|gi|507055561|ref|WP_016126482.1|	39.0	218	231	309	2.94e-53	172
k141_1207916_28	SARG|gi|488053456|ref|WP_002124853.1|	39.0	218	231	309	4.16e-53	172
k141_1207916_28	SARG|gi|488130770|ref|WP_002201978.1|	39.4	218	231	309	4.16e-53	172
k141_1207916_28	SARG|gi|488067981|ref|WP_002139378.1|	39.0	218	231	309	5.87e-53	172
k141_1207916_28	SARG|gi|487936534|ref|WP_002010000.1|	39.0	218	231	309	5.87e-53	172
k141_1207916_28	SARG|gi|542061059|gb|ERI11611.1|	37.2	226	231	316	1.40e-52	171
k141_1207916_28	SARG|gi|488068784|ref|WP_002140181.1|	39.0	218	231	309	1.65e-52	171
k141_1207916_28	SARG|gi|488120365|ref|WP_002191762.1|	38.5	218	231	309	2.33e-52	170
k141_1207916_28	SARG|gi|447057510|ref|WP_001134766.1|	38.5	218	231	309	4.64e-52	169
k141_1207916_33	NCBI|WP_050824634.1|1|1|tet(O)|tet(O)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(O)|AMR|tetracycline	35.1	154	401	639	2.67e-15	76.6
k141_1207916_40	CARD|gb|BAD59497.1|ARO:3000501|rpoB2	42.0	1308	1269	1162	0.0	967
k141_1207916_40	CARD|gb|WP_041777404.1|ARO:3004480|Bado_rpoB_RIF	41.2	1334	1269	1186	0.0	937
k141_1207916_40	megares|MEG_8674|Drugs|Rifampin|Rifampin-resistant_beta-subunit_of_RNA_polymerase_RpoB|RPOB_1	41.2	1334	1269	1186	0.0	937
k141_451938_6	SARG|gi|1035706844|ref|WP_064548272.1|	40.7	81	949	648	3.45e-10	62.8
k141_590369_2	megares|MEG_4091|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPB_1	35.5	1101	1137	1033	1.10e-229	683
k141_590369_2	SARG|gb|AEY83581|ARO:3000510|mupB	35.5	1101	1137	1033	1.10e-229	683
k141_590369_2	NCBI|WP_000163435.1|1|1|mupA|mupA|insensitivity|2|mupirocin|mupirocin|mupirocin-resistant_isoleucine--tRNA_ligase_MupA|AMR|mupirocin	35.8	1078	1137	1024	5.70e-227	676
k141_590369_2	megares|MEG_4089|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	35.8	1078	1137	1024	5.70e-227	676
k141_590369_2	megares|MEG_4090|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	35.7	1078	1137	1024	1.25e-225	672
k141_590369_2	SARG|gb|CAA53189|ARO:3000521|mupA	35.7	1078	1137	1024	1.25e-225	672
k141_590369_2	megares|MEG_3295|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|ILES_1	34.3	1149	1137	1107	1.60e-191	586
k141_590369_2	SARG|gb|ADP36409.1|ARO:3003730|Bifidobacteria	34.3	1149	1137	1107	1.60e-191	586
k141_383421_2	CARD|gb|AAC75137.1|ARO:3000794|mdtC	25.0	1028	1045	1025	2.82e-90	310
k141_383421_2	SARG|gb|AAG05914|ARO:3004075|MuxC	25.1	1034	1045	1036	3.01e-89	308
k141_383421_2	SARG|YP_001186705	24.9	1031	1045	1017	2.84e-88	305
k141_383421_2	CARD|gb|AAG07594.1|ARO:3000808|MexI	26.2	1026	1045	1029	4.16e-87	301
k141_383421_2	SARG|gb|BAE06006.1|ARO:3003705|mexN	25.0	1027	1045	1036	6.04e-84	293
k141_383421_2	SARG|gi|966403553|ref|WP_058447148.1|	25.8	1098	1045	1058	2.03e-83	291
k141_383421_2	SARG|CAY51926	24.7	1036	1045	1008	2.39e-82	288
k141_383421_2	SARG|YP_001350280	24.3	1034	1045	1018	5.08e-82	287
k141_383421_2	SARG|gb|CAH14033.1|ARO:3004100|LpeB	25.1	1040	1045	1014	1.67e-81	285
k141_383421_2	SARG|YP_792720	24.2	1034	1045	1018	8.27e-81	283
k141_797528_33	SARG|CAA37477	44.5	137	613	663	2.90e-28	119
k141_797528_33	SARG|FN594949.1.gene24.p01	43.1	130	613	640	3.21e-23	103
k141_797528_33	NCBI|WP_003454408.1|1|1|tet(44)|tet(44)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(44)|AMR|tetracycline	43.1	130	613	640	3.21e-23	103
k141_797528_33	SARG|Q02652	43.0	128	613	639	7.18e-22	99.0
k141_1140594_2	SARG|gi|823326845|ref|WP_047080664.1|	46.2	221	227	648	1.90e-60	199
k141_1140594_2	SARG|gi|895981299|ref|WP_049056431.1|	46.2	221	227	648	1.90e-60	199
k141_1140594_2	SARG|gi|823281237|ref|WP_047037467.1|	46.2	221	227	648	1.90e-60	199
k141_1140594_2	SARG|gi|895967513|ref|WP_049046752.1|	46.2	221	227	648	1.90e-60	199
k141_1140594_2	SARG|gi|779903733|ref|WP_045374054.1|	46.2	221	227	648	1.90e-60	199
k141_1140594_2	SARG|gi|823302270|ref|WP_047057473.1|	46.2	221	227	648	3.70e-60	198
k141_1140594_2	SARG|gi|976146774|ref|WP_059305359.1|	46.2	221	227	648	3.70e-60	198
k141_1140594_2	SARG|gi|1022664304|ref|WP_063420886.1|	46.2	221	227	648	3.70e-60	198
k141_1140594_2	SARG|gi|823309640|ref|WP_047064288.1|	46.2	221	227	648	3.70e-60	198
k141_1140594_2	SARG|gi|505807117|ref|WP_015704872.1|	46.2	221	227	648	3.70e-60	198
k141_1140594_4	CARD|gb|AAK37618.1|ARO:3005008|TxR	41.6	296	450	318	1.20e-65	212
k141_1140594_5	megares|MEG_7514|Drugs|Glycopeptide|VanL-type_regulator|VANSL_1	36.2	105	289	364	1.39e-11	63.2
k141_1140594_5	NCBI|WP_063856745.1|1|1|vanS-L|vanS-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-L|AMR|glycopeptide	36.2	105	289	364	1.39e-11	63.2
k141_1140594_17	SARG|gi|507044560|ref|WP_016115614.1|	30.7	254	252	306	2.73e-33	121
k141_1140594_17	SARG|gi|500448961|gb|EOP61695.1|	30.3	254	252	306	4.02e-32	118
k141_1140594_17	SARG|gi|500465078|gb|EOP76697.1|	30.3	254	252	306	5.62e-32	118
k141_1140594_17	SARG|gi|446048013|ref|WP_000125868.1|	26.9	212	252	648	1.37e-21	92.4
k141_1140594_17	CARD|gb|BAB80490.1|ARO:3007644|Cper_cplR	21.8	211	252	568	2.44e-08	53.1
k141_1140594_17	SARG|AXF35727.1	23.6	195	252	497	5.93e-06	45.8
k141_1140594_93	SARG|gb|AAC74000.1|ARO:3003950|msbA	37.0	527	602	582	4.92e-91	291
k141_1140594_93	SARG|gi|917172177|ref|WP_051778889.1|	33.5	511	602	620	1.96e-82	270
k141_1140594_93	SARG|gi|921231571|ref|WP_053176464.1|	33.5	511	602	620	2.74e-82	269
k141_1140594_93	SARG|gi|944009777|ref|WP_055601444.1|	33.0	518	602	628	4.60e-82	269
k141_1140594_93	SARG|gi|664042835|ref|WP_030582300.1|	32.7	514	602	604	7.22e-82	268
k141_1140594_93	SARG|gi|497748188|ref|WP_010062372.1|	33.1	516	602	605	1.03e-81	267
k141_1140594_93	SARG|gi|664556405|ref|WP_031071225.1|	31.0	600	602	602	1.35e-81	267
k141_1140594_93	SARG|gi|799286378|ref|WP_045936958.1|	33.3	511	602	620	1.46e-81	267
k141_1140594_93	SARG|gi|917127754|ref|WP_051734466.1|	33.3	511	602	620	1.46e-81	267
k141_1140594_93	SARG|gi|926294973|ref|WP_053631154.1|	33.3	511	602	620	1.46e-81	267
k141_1140594_96	CARD|gb|AAN28945.1|ARO:3003785|Ctra_murA_FOF	29.8	459	442	444	2.88e-48	170
k141_1140594_117	SARG|DQ144639.1.orf1.gene.p01	25.3	249	263	377	6.19e-11	60.8
k141_1140594_117	SARG|AY154657.2.orf0.gene.p01	24.7	255	263	386	1.64e-09	56.6
k141_1140594_117	megares|MEG_2759|Drugs|MLS|23S_rRNA_methyltransferases|ERM_1	24.7	255	263	386	1.64e-09	56.6
k141_1140594_117	SARG|gi|500047079|ref|WP_011727797.1|	24.3	255	263	386	9.58e-09	54.3
k141_801455_25	SARG|YP_002850805	27.8	684	685	652	1.60e-78	262
k141_801455_25	SARG|NP_348076	28.1	675	685	652	4.31e-78	261
k141_801455_25	SARG|ZP_02952732	27.5	684	685	652	2.25e-77	259
k141_801455_25	SARG|ZP_02632674	27.5	684	685	660	2.67e-77	259
k141_801455_25	SARG|L20800.gene.p01	27.5	684	685	652	1.17e-76	257
k141_801455_25	SARG|L42544.gene.p01	29.4	663	685	651	8.34e-73	247
k141_801455_25	SARG|AAV80410	29.4	663	685	651	1.16e-72	246
k141_801455_25	SARG|Q00937	27.2	658	685	641	6.14e-66	228
k141_801455_25	SARG|ZP_04557016	27.2	658	685	657	8.26e-66	228
k141_801455_25	megares|MEG_7173|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	26.8	668	685	629	4.76e-65	225
k141_870288_31	SARG|gi|639216333|ref|WP_024554080.1|	31.4	255	555	648	2.48e-17	84.3
k141_870288_31	SARG|gi|671541568|ref|WP_031525212.1|	34.3	216	555	648	7.62e-17	82.8
k141_870288_31	SARG|gi|896325272|ref|WP_049294291.1|	31.0	255	555	648	7.62e-17	82.8
k141_870288_31	SARG|gi|981224618|ref|WP_059445588.1|	30.5	236	555	646	1.01e-16	82.4
k141_870288_31	SARG|gi|836585048|ref|WP_047742322.1|	30.5	236	555	646	1.01e-16	82.4
k141_870288_31	SARG|gi|639209604|ref|WP_024547784.1|	34.3	216	555	648	1.01e-16	82.4
k141_870288_31	SARG|gi|779866095|ref|WP_045354445.1|	30.5	236	555	646	1.33e-16	82.0
k141_870288_31	SARG|gi|556487375|ref|WP_023335108.1|	30.9	236	555	646	1.33e-16	82.0
k141_870288_31	SARG|gi|1016275448|gb|AMX06027.1|	30.5	236	555	646	1.33e-16	82.0
k141_870288_31	SARG|gi|779956086|ref|WP_045403603.1|	30.5	236	555	646	1.76e-16	81.6
k141_870288_70	SARG|gb|AIK02012.1|ARO:3002579|AAC(6')-Ib8	76.5	34	44	225	3.98e-12	56.2
k141_1218376_1	SARG|gb|BAE06006.1|ARO:3003705|mexN	37.7	204	290	1036	4.30e-30	118
k141_1218376_1	SARG|gb|CAH14033.1|ARO:3004100|LpeB	32.0	247	290	1014	1.06e-29	117
k141_1218376_1	NCBI|AAN29241.1|1|1|bepE|bepE|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_permease_subunit_BepE|AMR|efflux	27.1	262	290	1051	3.04e-28	113
k141_1218376_1	CARD|gb|AAG03548.1|ARO:3003681|TriC	29.5	268	290	1015	1.86e-27	110
k141_1218376_1	SARG|gb|AAG05915.1|ARO:3004074|MuxB	30.2	248	290	1043	3.44e-27	110
k141_1218376_1	NCBI|AAN33534.1|1|1|bepG|bepG|efflux|1|EFFLUX|EFFLUX|multidrug_efflux_RND_transporter_permease_subunit_BepG|AMR|efflux	25.6	270	290	1074	1.17e-26	108
k141_1218376_1	SARG|YP_606823	26.9	264	290	1011	9.58e-26	105
k141_1218376_1	SARG|YP_001186705	27.2	254	290	1017	7.98e-25	103
k141_1218376_1	SARG|YP_792720	28.0	254	290	1018	1.08e-24	102
k141_1218376_1	SARG|YP_001350280	28.0	254	290	1018	1.08e-24	102
k141_740653_1	SARG|gb|APB03219.1|ARO:3003986|TaeA	41.2	500	557	648	1.47e-122	374
k141_740653_1	ResF|poxtA-Ef_1_WP094899500.1_1	29.9	489	557	538	2.09e-62	213
k141_740653_1	megares|MEG_8639|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|POXT_1	29.9	489	557	543	2.32e-62	213
k141_740653_1	NCBI|WP_094899500.1|1|1|poxtA-Ef|poxtA-Ef|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA-Ef|AMR|multidrug	29.9	489	557	543	2.32e-62	213
k141_740653_1	SARG|M80346.gene.p01	34.5	531	557	551	5.31e-62	212
k141_740653_1	megares|MEG_1491|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|CARA_1	34.5	531	557	551	5.31e-62	212
k141_740653_1	SARG|gb|AVI44920.1|ARO:3004470|poxtA	31.5	489	557	542	3.23e-59	204
k141_740653_1	NCBI|WP_209691075.1|1|1|poxtA2|poxtA|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA2|AMR|multidrug	31.5	489	557	544	3.36e-59	204
k141_740653_1	SARG|X63451.gene.p01	31.9	551	557	550	1.02e-58	203
k141_740653_1	megares|MEG_6558|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|SRMB_1	31.9	551	557	550	1.02e-58	203
k141_740653_4	SARG|gi|447057510|ref|WP_001134766.1|	30.8	227	236	309	9.39e-34	122
k141_740653_4	SARG|gi|445996719|ref|WP_000074574.1|	30.8	227	236	309	1.32e-33	122
k141_740653_4	SARG|gi|1043490477|ref|WP_065382463.1|	30.8	227	236	309	1.32e-33	122
k141_740653_4	SARG|gi|895736250|emb|COF64653.1|	30.8	227	236	309	1.32e-33	122
k141_740653_4	SARG|gi|445996726|ref|WP_000074581.1|	30.8	227	236	309	1.32e-33	122
k141_740653_4	SARG|gi|446110087|ref|WP_000187942.1|	30.8	227	236	309	1.32e-33	122
k141_740653_4	SARG|gi|884875933|emb|CKG93789.1|	30.8	227	236	309	1.32e-33	122
k141_740653_4	SARG|gi|445996723|ref|WP_000074578.1|	30.8	227	236	309	1.32e-33	122
k141_740653_4	SARG|gi|507054395|ref|WP_016125339.1|	30.8	227	236	309	1.32e-33	122
k141_740653_4	SARG|gi|445996724|ref|WP_000074579.1|	30.8	227	236	309	1.84e-33	121
k141_1289759_5	SARG|YP_001477378	62.9	89	90	406	8.95e-34	118
k141_1289759_5	SARG|ZP_04623896	59.6	89	90	380	6.74e-32	113
k141_1289759_5	SARG|ZP_04612558	59.6	89	90	404	1.29e-31	112
k141_1289759_5	SARG|YP_001871501	59.6	89	90	404	1.29e-31	112
k141_1289759_5	SARG|ZP_04631862	59.6	89	90	404	1.29e-31	112
k141_1289759_5	SARG|YP_001605796	59.6	89	90	404	1.29e-31	112
k141_1289759_5	SARG|ZP_04638972	58.4	89	90	404	2.50e-31	112
k141_1289759_5	SARG|ZP_04621517	59.6	89	90	404	2.50e-31	112
k141_1289759_5	SARG|YP_001401993	58.4	89	90	404	4.86e-31	111
k141_1289759_5	SARG|AAC60781	58.8	85	90	410	1.41e-30	110
k141_125538_2	SARG|gi|488374619|ref|WP_002444004.1|	25.2	440	454	452	8.02e-42	153
k141_125538_2	SARG|gi|505177635|ref|WP_015364737.1|	24.4	439	454	451	1.94e-39	146
k141_125538_2	SARG|ZP_04679156	24.4	439	454	451	7.06e-39	145
k141_125538_2	SARG|gi|1006223553|ref|WP_061745579.1|	23.6	441	454	451	6.34e-37	139
k141_125538_2	SARG|gi|686155635|ref|WP_031787393.1|	23.4	444	454	451	1.20e-36	139
k141_125538_2	SARG|gi|446573718|ref|WP_000651064.1|	23.2	444	454	451	1.65e-36	138
k141_125538_2	SARG|gi|686408548|ref|WP_031913080.1|	22.8	439	454	451	2.28e-36	138
k141_125538_2	SARG|ZP_03986195	22.8	439	454	451	3.14e-36	137
k141_125538_2	SARG|gi|516415429|ref|WP_017804827.1|	24.4	430	454	451	3.14e-36	137
k141_125538_2	SARG|gi|446573695|ref|WP_000651041.1|	22.8	439	454	451	3.14e-36	137
k141_127437_25	SARG|gi|757799830|ref|WP_043017032.1|	31.4	258	309	660	1.09e-34	132
k141_127437_25	SARG|gi|851965596|ref|WP_048234849.1|	31.0	258	309	660	3.32e-33	127
k141_127437_25	SARG|gi|1002399350|ref|WP_061382108.1|	30.6	258	309	660	6.16e-33	127
k141_127437_25	SARG|gi|507086291|ref|WP_016157032.1|	31.6	237	309	660	1.14e-32	126
k141_127437_25	SARG|YP_002850217	30.6	258	309	660	1.56e-32	125
k141_127437_25	SARG|gi|507083067|ref|WP_016153816.1|	31.6	237	309	660	2.12e-32	125
k141_127437_25	SARG|gi|489117806|ref|WP_003027650.1|	31.6	237	309	660	2.12e-32	125
k141_127437_25	SARG|gi|696375142|ref|WP_032949690.1|	31.6	237	309	660	2.12e-32	125
k141_127437_25	SARG|gi|765458296|ref|WP_044714032.1|	31.6	237	309	660	2.89e-32	125
k141_127437_25	SARG|gi|487613526|ref|WP_001735490.1|	29.3	259	309	660	5.35e-32	124
k141_335355_16	SARG|gi|445996710|ref|WP_000074565.1|	28.8	219	276	309	7.72e-21	89.0
k141_335355_16	SARG|gi|445996719|ref|WP_000074574.1|	29.3	225	276	309	2.02e-20	87.8
k141_335355_16	SARG|gi|895808656|emb|COR83787.1|	28.3	219	276	309	2.79e-20	87.4
k141_335355_16	SARG|gi|445996729|ref|WP_000074584.1|	28.2	220	276	309	3.84e-20	87.0
k141_335355_16	SARG|gi|895736250|emb|COF64653.1|	28.3	219	276	309	3.84e-20	87.0
k141_335355_16	SARG|gi|446110087|ref|WP_000187942.1|	28.3	219	276	309	3.84e-20	87.0
k141_335355_16	SARG|gi|445996714|ref|WP_000074569.1|	28.3	219	276	309	5.29e-20	86.7
k141_335355_16	SARG|gi|1043490477|ref|WP_065382463.1|	28.9	225	276	309	1.38e-19	85.5
k141_335355_16	SARG|gi|445996726|ref|WP_000074581.1|	28.9	225	276	309	1.38e-19	85.5
k141_335355_16	SARG|gi|445996723|ref|WP_000074578.1|	28.9	225	276	309	1.38e-19	85.5
k141_130411_8	SARG|gi|1035670474|ref|WP_064517458.1|	26.1	222	255	648	1.97e-08	53.5
k141_130411_8	SARG|gi|1035717981|ref|WP_064557480.1|	26.1	222	255	648	1.97e-08	53.5
k141_130411_8	SARG|gi|736472622|ref|WP_034494292.1|	26.1	222	255	648	1.97e-08	53.5
k141_130411_8	SARG|YP_001176128	23.5	247	255	646	2.64e-08	53.1
k141_130411_8	SARG|gi|974588181|ref|WP_059178476.1|	23.1	247	255	646	3.54e-08	52.8
k141_130411_8	SARG|gi|1035706844|ref|WP_064548272.1|	26.1	222	255	648	6.36e-08	52.0
k141_130411_8	SARG|gi|949731360|ref|WP_057072003.1|	22.6	248	255	646	8.51e-08	51.6
k141_130411_8	SARG|gi|1015876944|ref|WP_062856780.1|	22.6	248	255	646	8.51e-08	51.6
k141_130411_8	SARG|gi|1016942913|ref|WP_063144441.1|	22.8	237	255	646	8.51e-08	51.6
k141_130411_8	SARG|gi|1032819400|ref|WP_064325534.1|	23.9	222	255	646	8.51e-08	51.6
k141_130411_10	SARG|gb|AAC74000.1|ARO:3003950|msbA	36.2	528	611	582	1.05e-97	309
k141_130411_10	SARG|gi|917229923|ref|WP_051836635.1|	35.5	574	611	620	3.47e-94	301
k141_130411_10	SARG|gi|917166849|ref|WP_051773561.1|	34.7	574	611	620	1.43e-92	296
k141_130411_10	SARG|gi|917155568|ref|WP_051762280.1|	34.7	574	611	620	2.01e-92	296
k141_130411_10	SARG|gi|919568551|ref|WP_052871170.1|	34.8	574	611	620	2.82e-92	296
k141_130411_10	SARG|gi|772774655|ref|WP_045322518.1|	36.1	527	611	620	5.54e-92	295
k141_130411_10	SARG|gi|917203192|ref|WP_051809904.1|	35.7	527	611	620	1.53e-91	294
k141_130411_10	SARG|gi|921231571|ref|WP_053176464.1|	34.7	574	611	620	2.14e-91	293
k141_130411_10	SARG|gi|926351744|ref|WP_053683383.1|	35.1	527	611	648	2.15e-91	294
k141_130411_10	SARG|gi|917172177|ref|WP_051778889.1|	34.7	574	611	620	3.00e-91	293
k141_130843_9	SARG|gi|752682279|ref|WP_041330231.1|	34.1	349	330	349	2.01e-54	180
k141_130843_9	SARG|AAF71281	34.4	349	330	349	2.83e-54	180
k141_130843_9	SARG|DQ212986.1.gene8.p01	34.1	349	330	349	1.56e-53	178
k141_130843_9	SARG|gi|405945042|pdb|4FU0|A	34.1	349	330	357	1.90e-53	178
k141_130843_9	SARG|gi|1028100561|ref|WP_063856696.1|	33.5	349	330	349	1.20e-52	176
k141_130843_9	SARG|gi|765411304|ref|WP_044689514.1|	33.8	349	330	349	1.20e-52	176
k141_130843_9	SARG|gi|498467695|ref|WP_010773051.1|	30.5	341	330	352	1.64e-49	167
k141_130843_9	SARG|gb|ABX54687.1|ARO:3002910|vanL	30.4	349	330	349	1.64e-48	165
k141_130843_9	SARG|FJ872411.1.gene41.p01	29.2	343	330	352	1.34e-47	162
k141_130843_9	SARG|gi|1002798395|gb|AMN85478.1|	31.3	348	330	343	5.90e-47	160
k141_751188_9	SARG|gi|748767925|ref|WP_040019608.1|	24.2	236	256	623	2.09e-12	65.5
k141_751188_9	SARG|gb|APB03219.1|ARO:3003986|TaeA	22.9	227	256	648	2.85e-12	65.1
k141_751188_9	SARG|gi|926400371|ref|WP_053728483.1|	25.0	200	256	603	1.23e-11	63.2
k141_751188_9	SARG|gb|AAK76137.1|ARO:3000024|patA	23.8	210	256	564	2.16e-11	62.4
k141_751188_9	SARG|gi|917166849|ref|WP_051773561.1|	27.5	171	256	620	2.24e-11	62.4
k141_751188_9	megares|MEG_4316|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	27.5	211	256	655	3.07e-11	62.0
k141_751188_9	megares|MEG_4304|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	27.5	211	256	655	4.13e-11	61.6
k141_751188_9	SARG|gb|AKA86814|ARO:3003746|optrA	27.5	211	256	655	4.13e-11	61.6
k141_751188_9	SARG|gi|953808775|ref|WP_058042812.1|	24.9	205	256	608	5.42e-11	61.2
k141_751188_9	SARG|gi|817122037|ref|WP_046494699.1|	24.0	217	256	613	5.43e-11	61.2
k141_751188_24	SARG|CP001581.1.gene3143.p01	32.5	345	343	344	1.13e-47	163
k141_751188_24	SARG|gb|CAL84423.1|ARO:3004146|cfrC	31.0	345	343	344	9.71e-45	155
k141_751188_24	SARG|gb|AGZ55247.1|ARO:3002814|clbA	31.5	343	343	349	1.15e-43	152
k141_751188_24	NCBI|WP_002349981.1|1|1|cfr(B)|cfr(B)|target_modification|2|CHLORAMPHENICOL/CLINDAMYCIN/LINEZOLID/RETAPAMULIN/STREPTOGRAMIN_B/VIRGINIAMYCIN|LINCOSAMIDE/OXAZOLIDINONE/PHENICOL/PLEUROMUTILIN/STREPTOGRAMIN|23S_rRNA_(adenine(2503)-C(8))-methyltransferase_Cfr(B)|AMR|multidrug	31.0	348	343	349	2.26e-43	152
k141_751188_24	SARG|gb|CDF47262.1|ARO:3004649|cfr(B)	31.0	348	343	349	2.26e-43	152
k141_751188_24	SARG|gb|BAH45481.1|ARO:3002815|clbB	32.7	339	343	343	2.76e-43	151
k141_751188_24	SARG|gb|AIX48090.1|ARO:3004599|clcD	31.0	348	343	349	6.18e-43	150
k141_751188_24	SARG|gb|ACX65640.1|ARO:3003907|cipA	32.0	331	343	346	8.09e-43	150
k141_751188_24	SARG|AXY65402.1	29.8	339	343	357	2.11e-41	147
k141_751188_24	NCBI|WP_032491462.1|1|1|cfr|cfr|target_modification|2|CHLORAMPHENICOL/CLINDAMYCIN/FLORFENICOL/LINEZOLID/STREPTOGRAMIN_B/TIAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/OXAZOLIDINONE/PHENICOL/PLEUROMUTILIN/STREPTOGRAMIN|23S_rRNA_(adenine(2503)-C(8))-methyltransferase_Cfr|AMR|multidrug	29.2	342	343	349	2.58e-40	144
k141_1162534_7	SARG|AUI09862.1	33.7	273	297	287	2.89e-34	125
k141_1162534_7	SARG|AJ459418.gene.p01	30.1	259	297	263	8.17e-28	107
k141_1162534_7	SARG|gi|970263436|ref|WP_058647620.1|	30.1	259	297	263	1.14e-27	107
